Regulation of mitochondrial morphology and cristae architecture by the TLR4 pathway in human skeletal muscle

In skeletal muscle (SkM), a reduced mitochondrial elongate phenotype is associated with several metabolic disorders like type 2 diabetes mellitus (T2DM). However, the mechanisms contributing to this reduction in mitochondrial elongate phenotype in SkM have not been fully elucidated. It has recently been shown in a SkM cell line that toll-like receptor 4 (TLR4) contributes to the regulation of mitochondrial morphology. However, this has not been investigated in human SkM. Here we found that in human SkM biopsies, TLR4 protein correlated negatively with Opa1 (pro-mitochondrial fusion protein). Moreover, the incubation of human myotubes with LPS reduced mitochondrial size and elongation and induced abnormal mitochondrial cristae, which was prevented with the co-incubation of LPS with TAK242. Finally, T2DM myotubes were found to have reduced mitochondrial elongation and mitochondrial cristae density. Mitochondrial morphology, membrane structure, and insulin-stimulated glucose uptake were restored to healthy levels in T2DM myotubes treated with TAK242. In conclusion, mitochondrial morphology and mitochondrial cristae seem to be regulated by the TLR4 pathway in human SkM. Those mitochondrial alterations might potentially contribute to insulin resistance in the SkM of patients with T2DM.

[1]  H. Zbinden-Foncea,et al.  Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism. , 2023, Metabolism: clinical and experimental.

[2]  P. Yu-Wai-Man,et al.  OPA1 disease-causing mutants have domain-specific effects on mitochondrial ultrastructure and fusion , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Gourabamani Swalsingh,et al.  Structural functionality of skeletal muscle mitochondria and its correlation with metabolic diseases. , 2022, Clinical science.

[4]  Wei Li,et al.  Sirt3 mitigates LPS‐induced mitochondrial damage in renal tubular epithelial cells by deacetylating YME1L1 , 2022, Cell proliferation.

[5]  B. Everts,et al.  The NLRP3 inflammasome contributes to inflammation‐induced morphological and metabolic alterations in skeletal muscle , 2022, Journal of cachexia, sarcopenia and muscle.

[6]  H. Zbinden-Foncea,et al.  Severe COVID‐19 correlates with lower mitochondrial cristae density in PBMCs and greater sitting time in humans , 2022, Physiological Reports.

[7]  B. Morio,et al.  The fasting‐feeding metabolic transition regulates mitochondrial dynamics , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. Houmard,et al.  Pharmacological inhibition of dynamin‐related protein 1 attenuates skeletal muscle insulin resistance in obesity , 2021, Physiological reports.

[9]  H. Zbinden-Foncea,et al.  Low abundance of Mfn2 protein correlates with reduced mitochondria‐SR juxtaposition and mitochondrial cristae density in human men skeletal muscle: Examining organelle measurements from TEM images , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  S. Harper,et al.  Is Upregulation of Sarcolipin Beneficial or Detrimental to Muscle Function? , 2021, Frontiers in Physiology.

[11]  L. Deldicque,et al.  Acute and Chronic Effects of High Frequency Electric Pulse Stimulation on the Akt/mTOR Pathway in Human Primary Myotubes , 2020, Frontiers in Bioengineering and Biotechnology.

[12]  A. Contreras-Ferrat,et al.  Fibroblast growth factor-21 potentiates glucose transport in skeletal muscle fibers. , 2020, Journal of molecular endocrinology.

[13]  H. Zbinden-Foncea,et al.  Relative lipid oxidation associates directly with mitochondrial fusion phenotype- and mitochondria-sarcoplasmic reticulum interactions in human skeletal muscle. , 2020, American journal of physiology. Endocrinology and metabolism.

[14]  K. Shimomura,et al.  TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice , 2020, Scientific Reports.

[15]  Xinping Luo,et al.  TLR4 Activation Promotes the Progression of Experimental Autoimmune Myocarditis to Dilated Cardiomyopathy by Inducing Mitochondrial Dynamic Imbalance , 2018, Oxidative medicine and cellular longevity.

[16]  B. Gurd,et al.  Coordination of mitochondrial biogenesis by PGC-1α in human skeletal muscle: A re-evaluation. , 2018, Metabolism: clinical and experimental.

[17]  D. Turnbull,et al.  Mitochondrial Nanotunnels , 2017, Trends in cell biology.

[18]  S. Maurya,et al.  Mild cold induced thermogenesis: are BAT and skeletal muscle synergistic partners? , 2017, Bioscience reports.

[19]  K. Sakamoto,et al.  Lipopolysaccharide inhibits myogenic differentiation of C2C12 myoblasts through the Toll-like receptor 4-nuclear factor-κB signaling pathway and myoblast-derived tumor necrosis factor-α , 2017, PloS one.

[20]  Martin Picard,et al.  The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy , 2016, Scientific Reports.

[21]  K. Mihara,et al.  Drp1-dependent mitochondrial fission via MiD49/51 is essential for apoptotic cristae remodeling , 2016, The Journal of cell biology.

[22]  D. Bernlohr,et al.  Insulin Stimulates Mitochondrial Fusion and Function in Cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 Signaling Pathway , 2013, Diabetes.

[23]  N. Musi,et al.  Effect of Lipopolysaccharide on Inflammation and Insulin Action in Human Muscle , 2013, PloS one.

[24]  M. Febbraio,et al.  Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.

[25]  Y. Tsai,et al.  Mitochondrial Fission Contributes to Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle , 2011, Molecular and Cellular Biology.

[26]  L. Heilbronn,et al.  Toll-like receptor 4 modulates skeletal muscle substrate metabolism. , 2010, American journal of physiology. Endocrinology and metabolism.

[27]  S. Devaraj,et al.  Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects , 2010, Diabetes Care.

[28]  T. Kaisho,et al.  Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model , 2009, British journal of pharmacology.

[29]  R. DeFronzo,et al.  Elevated Toll-Like Receptor 4 Expression and Signaling in Muscle From Insulin-Resistant Subjects , 2008, Diabetes.

[30]  O. Pedersen,et al.  Expression profiling of insulin action in human myotubes: induction of inflammatory and pro-angiogenic pathways in relationship with glycogen synthesis and type 2 diabetes. , 2004, Biochemical and biophysical research communications.

[31]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[32]  P. Poulsen,et al.  The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity. , 2002, Diabetes.

[33]  A. Baron,et al.  Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. , 1988, The American journal of physiology.